Diagnosing and Managing Multiple Sclerosis: A Personalized Approach

Program Overview

Multiple sclerosis (MS) is one of the leading causes of disability and many efforts have been implemented to help expedite diagnosis and initiate early effective treatment. With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of MS, such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis. In this supplement, these topics will be addressed along with recognizing treatment failure, knowing when to switch therapies, and how to incorporate patient preference in treatment-related decisions

Credit Expired

CE Credit Expired

Expires: September 29, 2020

Target Audience

This educational activity is designed for neurologists, PAs, NPs, and allied HCPs who diagnose and manage patients with multiple sclerosis (MS).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Recognize and diagnose the spectrum of multiple sclerosis (MS), from clinically isolated syndrome (CIS) to the various forms of MS (ie, relapsing-remitting and progressive) using established, updated, clinical imaging and laboratory criteria
Appropriately use available and emerging disease-modifying therapies (DMTs) for MS based on their efficacy, safety, and tolerability profiles, as well as their approved or anticipated indications for the various forms of MS
Recognize and manage treatment failure, including switching DMTs
Monitor disease and patient outcomes, including patient adherence, according to recommended protocols
Use shared decision making when prescribing DMTs to improve treatment adherence and patient outcomes
Appropriately manage MS in women of child-bearing age

Activity Faculty

Patricia K. Coyle, MD, FAAN, FANA

Professor and Vice Chair, Clinical Affairs
Department of Neurology
Director, MS Comprehensive Care Center
Stony Brook University Hospital
Stony Brook, NY

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Featured RMEI CE Activities

Diagnosing and Managing Multiple Sclerosis: A Personalized Approach

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Patricia K. Coyle, MD, FAAN, FANA

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Collaboration Nation: Interprofessional Perspectives on Immunotherapy and Team-Based Care for Non-Melanoma Skin Cancer

Spinal Muscular Atrophy: An Interprofessional Approach

Tackling the Problem Head On: Key Considerations for CMV in the Post-Transplant Setting: A Care Team Forum®

Subscribe